CN101233876B - Low lactose liquid state milk suitable for baby from 0 to 12 months old - Google Patents
Low lactose liquid state milk suitable for baby from 0 to 12 months old Download PDFInfo
- Publication number
- CN101233876B CN101233876B CN2008100068259A CN200810006825A CN101233876B CN 101233876 B CN101233876 B CN 101233876B CN 2008100068259 A CN2008100068259 A CN 2008100068259A CN 200810006825 A CN200810006825 A CN 200810006825A CN 101233876 B CN101233876 B CN 101233876B
- Authority
- CN
- China
- Prior art keywords
- milk
- accounts
- dha
- calcium
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004080 milk Anatomy 0.000 title claims abstract description 56
- 235000013336 milk Nutrition 0.000 title claims abstract description 55
- 239000008267 milk Substances 0.000 title claims abstract description 55
- 239000008101 lactose Substances 0.000 title claims abstract description 15
- 239000007788 liquid Substances 0.000 title claims description 18
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 20
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 20
- 235000020190 lactose-free milk Nutrition 0.000 claims abstract description 18
- 239000005862 Whey Substances 0.000 claims abstract description 15
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 15
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 15
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 14
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 14
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 14
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 14
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 14
- 235000018102 proteins Nutrition 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- 239000008158 vegetable oil Substances 0.000 claims abstract description 12
- 229960001231 choline Drugs 0.000 claims abstract description 11
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 11
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 11
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 70
- 235000021342 arachidonic acid Nutrition 0.000 claims description 35
- 229940114079 arachidonic acid Drugs 0.000 claims description 35
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 20
- 235000010755 mineral Nutrition 0.000 claims description 20
- 239000011707 mineral Substances 0.000 claims description 20
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 239000011575 calcium Substances 0.000 claims description 16
- 229960005069 calcium Drugs 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 16
- 206010012601 diabetes mellitus Diseases 0.000 claims description 16
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 16
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000001465 calcium Nutrition 0.000 claims description 13
- 235000014121 butter Nutrition 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 12
- 235000019198 oils Nutrition 0.000 claims description 12
- 229960003080 taurine Drugs 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 239000011701 zinc Substances 0.000 claims description 11
- 229910052725 zinc Inorganic materials 0.000 claims description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 10
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 10
- 229910052802 copper Inorganic materials 0.000 claims description 10
- 239000010949 copper Substances 0.000 claims description 10
- 229960000367 inositol Drugs 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 9
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 claims description 9
- 239000011630 iodine Substances 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 229910052748 manganese Inorganic materials 0.000 claims description 9
- 239000011572 manganese Substances 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 210000000481 breast Anatomy 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 claims description 7
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 7
- 229950006790 adenosine phosphate Drugs 0.000 claims description 7
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 7
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 7
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 229940091250 magnesium supplement Drugs 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- DKHJWWRYTONYHB-UHFFFAOYSA-N CPP Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1 DKHJWWRYTONYHB-UHFFFAOYSA-N 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 241000206575 Chondrus crispus Species 0.000 claims description 3
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 235000010216 calcium carbonate Nutrition 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
- 239000001354 calcium citrate Substances 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 3
- 235000011010 calcium phosphates Nutrition 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 2
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000011706 ferric diphosphate Substances 0.000 claims description 2
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 2
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 2
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 2
- 239000004225 ferrous lactate Substances 0.000 claims description 2
- 235000013925 ferrous lactate Nutrition 0.000 claims description 2
- 229940037907 ferrous lactate Drugs 0.000 claims description 2
- 239000011790 ferrous sulphate Substances 0.000 claims description 2
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000004337 magnesium citrate Substances 0.000 claims description 2
- 235000002538 magnesium citrate Nutrition 0.000 claims description 2
- 229960005336 magnesium citrate Drugs 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229940099596 manganese sulfate Drugs 0.000 claims description 2
- 239000011702 manganese sulphate Substances 0.000 claims description 2
- 235000007079 manganese sulphate Nutrition 0.000 claims description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims 1
- 229940082629 iron antianemic preparations Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 239000005018 casein Substances 0.000 abstract description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 3
- 235000021240 caseins Nutrition 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 abstract description 2
- 239000006071 cream Substances 0.000 abstract description 2
- 239000008234 soft water Substances 0.000 abstract description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 abstract 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- 108010001441 Phosphopeptides Proteins 0.000 abstract 1
- 239000002366 mineral element Substances 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 229940046001 vitamin b complex Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 22
- 235000020256 human milk Nutrition 0.000 description 16
- 210000004251 human milk Anatomy 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 12
- 235000013350 formula milk Nutrition 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 10
- 235000019483 Peanut oil Nutrition 0.000 description 8
- 235000005687 corn oil Nutrition 0.000 description 8
- 239000002285 corn oil Substances 0.000 description 8
- 239000000312 peanut oil Substances 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 6
- 229930003316 Vitamin D Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 229960000304 folic acid Drugs 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 6
- 239000011724 folic acid Substances 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 229940055726 pantothenic acid Drugs 0.000 description 6
- 235000019161 pantothenic acid Nutrition 0.000 description 6
- 239000011713 pantothenic acid Substances 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 229930003448 Vitamin K Natural products 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 235000019158 vitamin B6 Nutrition 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 235000019168 vitamin K Nutrition 0.000 description 5
- 239000011712 vitamin K Substances 0.000 description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 229940011671 vitamin b6 Drugs 0.000 description 5
- 229940046010 vitamin k Drugs 0.000 description 5
- 102000004407 Lactalbumin Human genes 0.000 description 4
- 108090000942 Lactalbumin Proteins 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- -1 lactose carbohydrate Chemical class 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 235000020185 raw untreated milk Nutrition 0.000 description 3
- 235000020122 reconstituted milk Nutrition 0.000 description 3
- 238000012859 sterile filling Methods 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 230000008271 nervous system development Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008542 thermal sensitivity Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to milk and a method for preparing thereof, in particular to fluid milk applicable for infants of 0-12 months old, which belongs to a milk technical field. The milk comprises 18-50 percent of low-lactose milk or lactose-free milk, 0.6-1.72 percent of whey isolated protein, 3.1-8.5 percent of specific carbohydrate, 0.37-1.97 percent of anhydrous cream, 0.35-2.5 percent of vegetable oil, 0.01-0.6 percent of emulsifier, 3-10mg/100g of ethylamine sulfonic acid, 1-7mg/100g of nucleotide, 20-30mg/100g of casein phospho peptides, 1-21mg/100g of DHA, 4-30mg/100g of ARA, 4-15mg/100g of lactoferrin, 50-70mg/100g of GOS, 40-60mg/100g of FOS, 5-28mg/100g of choline, 5-28mg/100g of phaseomannite, 0.007-0.03 percent of Vitamin B complex, 0.00005-0.08 percent of complex mineral element (by elements) and soft water for the rest percentage.
Description
Technical field
The present invention relates to a kind of milk and preparation method thereof, particularly a kind of low lactose liquid condition milk for baby that is applicable to 0-12 month.Belong to the dairy technology field.
Background technology
Babies is significant in life period, and breast milk is undoubtedly the optimal wholefood of baby.Yet owing to reasons such as working condition, occupation, diseases, the nursing present situation of breast milk is unsatisfactory.Show that according to interrelated data China comes into being to 12 months baby breastfeeding rate: the city is about 20%, and the rural area is about 60%.And infant's milk powder substitute kind is limited on the present China market, and nutritional labeling is not comprehensive yet, and the infant formula of therefore producing reasonably, be fit to infant growth is extremely urgent.
Concerning the baby, best food is breast milk, because the composition that contains the necessary nutriment of infant physical growth in the breast milk and strengthen infant immunity.But in the society, often cause a lot of women breast-feeding their children to provide enough breast milks for the baby for various reasons now, we just have to seek a kind of method, obtain a kind of substitute that can replace breast milk in some sense.
Milk be till settled the present people from occurring in nature the most approaching perfect a kind of food that can obtain, animal protein, butter oil and vitamin etc. that it not only can provide health and brain to grow needed high-quality to people, but also be the optimal selection of calcium replenishing.
But very big difference is arranged on the composition of breast milk and milk, and wherein for example aliphatic acid is formed and breast milk has very big difference, lacks linoleic acid plus linolenic acid, also lacks ARA and DHA.Have a lot of baby milks to make every effort to can accomplish with breast milk approaching in the prior art, people are always constantly exploring and effort for this reason, on composition and function, the proportioning components of baby milk more and more near breast milk.
Simultaneously, in existing society, people's rhythm of life is than very fast, loaded down with trivial detailsly occurs such as misplacing problems such as ratio, pollution easily for the boiling water of cooling for baby is one towards milk powder.So making every effort to obtain a kind of baby's liquid milk always, people come to substitute to a certain extent baby milk.But owing to technical reason, such as liquid condition milk for baby in sterilization protein precipitation or the like problem can take place.
Summary of the invention
[goal of the invention]
Purpose of the present invention: invent a kind of low lactose liquid condition milk for baby that is applicable to 0-12 month, it not only can satisfy baby's nutritional need, and convenient easy-to-use, can keep the stable of liquid proterties simultaneously.
The objective of the invention is trophic component according to infant and breast milk, with diabetic milk or lactose-free milk (or similarly restoring diabetic milk, lactose-free milk), whey isolate protein, vegetable oil, to add particular carbon hydrate etc. be raw material, preferred aseptic online adding technique, according to the breast milk composition ratio, increased lactalbumin, the amount that makes casein and lactalbumin is is easily digested and assimilated by baby near breast milk; Add compound sugar, improve intestinal environment; Add the lactose carbohydrate supplementation; Add taurine, 22 carbon, six diluted acids, arachidonic acid, promote the feeding infant nervous system development; Add lactoferrin, nucleotides etc., the promotion immunocyte is engulfed external germ, improves baby's immunity.The prescription of the present invention's design makes the fluid milk nutritional labeling more reasonable, and infantile health is grown up and growth to satisfy.This product is compared with fresh milk and ordinary powdered milk, has that nutrition-allocated proportion science, local flavor are aromatic, the advantage of instant.The designed baby milk of the present invention is applicable to 0-12 month the consumption by infants of lactose intolerance phenomenon.
[technology contents]
Product of the present invention is achieved in that
A kind of low lactose liquid condition milk for baby that is applicable to 0-12 month, wherein, comprise diabetic milk or lactose-free milk (or similar reconstituted milk), whey isolate protein, particular carbon hydrate, anhydrous butter oil, vegetable oil, emulsifying agent, taurine, nucleotides, CPP, DHA (DHA), arachidonic acid (ARA), lactoferrin, galactooligosaccharide (GOS), FOS (FOS), choline, inositol, B B-complex, complex mineral prime element, water; Wherein wt part and ratio are:
Wherein diabetic milk or lactose-free milk (also can be similar reconstituted milk) account for 18%-50% (being preferably 20%-30%); whey isolate protein accounts for 0.6%-1.72% (being preferably 0.82%-1.56%); the particular carbon hydrate accounts for 3.1%-8.5% (being preferably 6.24%-7.9%); anhydrous butter oil accounts for 0.37-1.97% (being preferably 0.74%-1.05%); vegetable oil accounts for 0.35%-2.5% (being preferably 0.35%-1.2%); emulsifying agent 0.01-0.6% (being preferably 0.1%-0.4%); taurine accounts for 3-10mg/100g; nucleotides accounts for 1-7mg/100g; CPP accounts for 20-30mg/100g; DHA (DHA) accounts for 1-21mg/100g; arachidonic acid (ARA) accounts for 4-30mg/100g; lactoferrin accounts for 4-15mg/100g; galactooligosaccharide (GOS) accounts for 50-70mg/100g; FOS (FOS) accounts for 40-60mg/100g; choline accounts for 5-28mg/100g; inositol accounts for 5-28mg/100g; B B-complex accounts for 0.007%-0.03%; complex mineral prime element 0.00005%-0.08% (in element), all the other are soft water.
Above-mentioned diabetic milk is meant that milk is through the lactase hydrolysis, lactose hydrolysis ratio is at the milk more than 90%, lactose-free milk is meant that use lactase hydrolysis and membrane separation technique acquisition lactose hydrolysis ratio reach the milk more than 99%, and similarly reconstituted milk is meant the diabetic milk or the lactose-free milk of low-lactose milk powder, lactose-free milk powder and other similar dryings, powdered dairy products recovery back acquisition.
Above-mentioned whey isolate protein requires lactose content below 1%.
Above-mentioned vegetable oil is selected from: several or multiple combination wherein of soybean oil, peanut oil, sunflower oil, corn oil, or can further add fish oil.
Above-mentioned vegetable oil is selected from: peanut oil, soybean oil, corn oil, the ratio weight portion is: peanut oil accounts for that 0.05%-0.2%, soybean oil account for 0.2%-0.7%, corn oil accounts for 0.1%-0.4%.
Above-mentioned emulsifying agent, stabilizing agent are selected from: phosphatide, carragheen, guar gum, locust bean gum, go alone ester, one or more combinations of sucrose ester; Its addition is the 0.01-0.6% weight ratio; Preferable range is 0.1%-0.4%.
Above-mentioned particular carbon hydrate is selected from: the composition of one or more carbohydrate such as glucose, starch, dextrin, sucrose, galactolipin, maltose, corn syrup.
Above-mentioned nucleotides comprises: adenosine 5 '-phosphate, guanosine 5 '-phosphate, cytidine 5 '-phosphate, uridine 5 '-phosphate, inosine 5 '-phosphate, its ratio can be conventional arbitrary proportion combinations.
The content of above-mentioned B B-complex is (every 100g liquid milk):
Retinol1 50-500IU, vitamin D
330-50IU, vitamin E 0.4-2.8IU, vitamin C 3-40mg, prokeyvit-10 μ g, Cobastab
130-120 μ g, Cobastab
230-120 μ g, Cobastab
630-60 μ g, Cobastab
120.01-0.15 μ g, nicotinic acid 0.25-0.75mg, pantothenic acid 200-500 μ g, folic acid 4-15 μ g, biotin 1-3 μ g.
Above-mentioned complex mineral prime element is the one or more combination in following, its content is (every 100g liquid milk): calcium 40-100mg, phosphorus 20-70mg, magnesium 4-10mg, potassium 50-140mg, iron 0.5-1.6mg, zinc 0.3-1mg, sodium 10-50mg, iodine 4-40 μ g, copper 30-100 μ g, manganese 3.4-75 μ g, wherein:
One or more iron preparation combinations such as iron is ferrous by grape acid, ferrous sulfate, ferrous lactate, ironic citrate, ferric pyrophosphate provide;
Zinc is provided by one or more zinc preparation combinations such as zinc sulfate, zinc gluconate, zinc lactate, zinc chloride;
Calcium is provided by one or more calcium preparation combinations such as milk calcium, calcium citrate, calcium phosphate, calcium chloride, calcium carbonate, calcium lactate;
Magnesium is provided by one or more magnesium preparation combinations such as magnesium sulfate, magnesium chloride, magnesium citrate;
Iodine is provided by KI;
Manganese is provided by manganese sulfate;
Copper is provided by copper sulphate.
Above-mentioned DHA derives from algae, preferred DHA uses stability material embedding (preferred coating material is: converted starch, maltodextrin) before use, when adding DHA, add the arachidonic acid of DHA weight more than 1.05 times at least, preferred AA and DHA ratio 1.8~2.3: 1.Arachidonic acid (AA) and DHA (DHA) are the essential fatty acids of human early development.Cerebral gray matter 22.1%, 23.9% the constituting of white matter by phosphatide, retinal photoreceptor also contains abundant phosphatide, and the aliphatic acid that constitutes phosphatide mainly is arachidonic acid (AA) and DHA.Take in the DHA ratio when too high, the level of AA then descends in the tissue, and the minimizing of AA is not only influential to the film function, and also influential to its synthetic 20 carbonizable substances (prostaglandin and thromboxane), thereby influences the perfect of the growth of organ and cell function; And when the ratio of AA is too high, can suppress the synthetic of DHA again.The balance that keeps AA and DHA for infant's particular importance, is added DHA separately and may be caused the unbalance condition of formulated infant milk in baby milk, thereby causes that unusual tissue fat acid constitutes.The preferred ratio 1.8~2.3: 1 of AA and DHA.
Advantage: DHA can select to derive from algae.Algae is in the bottom of marine food chain, and wherein the DHA that is rich in is without the food chain transmission, safety non-pollution and do not contain any pigment, and the algae DHA oxidation resistance is stronger, is difficult for oxidation and becomes raw meat, is easy to be digested and assimilated by the infant.The DHA that extracts from abyssal fishes fat contains EPA, can cause damage to infant's blood vessel.DHA can use converted starch, the embedding of maltodextrin equistability material before using, and is more conducive to product and stablizes, and is difficult for oxidation and produces bad flavor.Add arachidonic acid AA and the preferred ratio 1.8~2.3: 1 of DHA more than 1.05 times.
In addition, in the selection of mineral matter element, kind and quantity that the present invention adds mineral matter according to the nutrient content decision of deisgn product.Advantage: the mineral matter element of selection is colourless, tasteless, not obvious influence the character of milk, can be water-soluble, chemical property stable, absorptivity is high, bad enzyme reaction in the milk is not had obvious facilitation, has suitable proportion.
Preferably milk calcium, calcium carbonate, calcium citrate, calcium phosphate etc. of calcium wherein, the calcium ion and calcium chloride dissociates out in solution easily can increase the unstability under the milk heating condition, may cause bad reactions such as curdled milk.
Excessive copper, iron can promote the oxidation of butterfat, vegetable oil, cause that liquid milk produces bad flavor.
Product of the present invention adopts conventional mixing interpolation pattern preparation to get final product, and preferred preparation technology is as follows in detail:
Raw milk is checked and accepted:
Be primarily aimed at acidity, fat, real milk solids, proportion, mingle (starch, alkali, salt, nitrite etc.), antibiotic, taste smell etc. and detect, qualified high-quality milk is as raw milk.Harmful material in the strict control milk is as nitrate, residues of pesticides, antibiotic etc.
The raw milk preliminary treatment:
Cow's milk is removed bigger foreign matter, impurity through gauze or duplex strainer coarse filtration; Through centrifugal clean breast, the breast epithelial tissue that remove tiny dirt, comes off, leucocyte etc., reach highly clean breast, improve the quality of products.In order to obtain the finished product that liptinite becomes component, must carry out standardization, the balance of index such as reach between butter oil and the non-fat solid.Storage temperature is about 4 ℃.
Batching:
Diabetic milk or lactose-free milk are pumped into mixing tank.
Add water and whey isolate protein at 45 ℃, add particular carbon hydrate (glucose, sucrose), CPP, lactoferrin, choline, inositol mix restore evenly after, add mixing tank.
Anhydrous butter oil+DHA+ARA+ vegetable oil+liposoluble vitamin+emulsifier
Vegetable oil mixes in the cream more than 45 ℃ with liposoluble vitamin, DHA, ARA, emulsifier again, adds mixing tank.
FOS, GOS mix with water, add water soluble vitamin, after mixing, add mixing tank.
Mineral matter adds mixing tank with after water mixes.
Taurine, nucleotides mix the back and add mixing tank with water.
Stirring, mixing, constant volume
After material adds mixing tank, stir 5-20min, and keep the skin wet constant volume.
Preheating and homogeneous
Preheating: preheat temperature is 65-90 ℃.
Homogeneous: homogenization pressure: gross pressure is 18-25Mpa, and first class pressure is 10-20Mpa, and secondary pressure is 8-10Mpa.
The UHT sterilization
Sterilising temp is 137-142 ℃, and sterilizing time is 2-4 second.UHT sterilization can be adopted tubular type steam sterilizing, board-like steam sterilizing, the sterilization of hanging-panel steaming vapour, steam-sprayed, multiple sterilization method such as steam is pouring-in.
Cooling:
The milk of ultra high temperature short time sterilization is cooled to about 15-30 ℃.Milk after the sterilization enters aseptic jar.
Aseptic interpolation
For the thermal sensitivity nutrition composition, as vitamin C, lactoferrin, CPP etc., the back adding technology of can preferably sterilizing.Being the thermal sensitivity nutrient deposits in sterile bag (or jar etc.) with liquid germ-free condition, connects aseptic add-on system, adds heat-sensitive component to aseptic jar or quantitatively add pipeline to.
For heat-sensitive component, also can adopt the preceding processing of sterilization, improve addition, remedy the loss amount in the hot-working.
Sterile filling, finished product
Sterile filling is to packing, and the product through being up to the standards enters warehouse for finished product.
Sterile filling is to packing, and the product through being up to the standards enters warehouse for finished product.
This product can adopt carton package, plastic bottle packing; Also can adopt packings such as vial, tinplate.
[invention effect]
1, the objective of the invention is trophic component according to infant and breast milk, with diabetic milk or lactose-free milk (or similarly restoring diabetic milk, lactose-free milk), whey isolate protein, vegetable oil, to add particular carbon hydrate etc. be raw material, the low lactose baby milk of design, the baby who satisfies low lactose intolerance drinks.
2, according to the breast milk composition ratio, increased lactalbumin, the amount that makes casein and lactalbumin is is easily digested and assimilated by baby near the breast milk ratio; Add compound sugar, improve intestinal environment; Add the lactose carbohydrate supplementation; Add taurine, 22 carbon, six diluted acids, arachidonic acid, promote the feeding infant nervous system development.
3, the present invention also preferably adds CPP, lactoferrin, nucleotides etc. especially except interpolation necessary multivitamin of infant growth and trace element, and the promotion immunocyte is engulfed external germ, improves baby's immunity.The prescription of the present invention's design makes the fluid milk nutritional labeling more reasonable, and infantile health is grown up and growth to satisfy.
4, preferred aseptic online adding technique is stability, the security of the contained heat-sensitive component of this product guarantee that provides important.
The specific embodiment
Embodiments of the present invention are intended to explain invention; rather than restriction protection scope of the present invention; the any those of ordinary skill in this area all should be able to know clearly and understand; to specifications disclosed proportion be can completely inerrably implement of the present invention; any difference slightly on the nutrition that causes because of the difference in milk milk source should be as the embodiment of the invention and the inconsistent reason of specification; so the present invention is intended to protect the aim of adding nutriment, rather than ratio especially strictly will be limited on the some concrete numerical value.
* because the difference of dairy product itself, can't know especially in an embodiment and limit strictly that respectively to add in the complete and specification of composition restricted portion identical that following examples also all equally.
Embodiment 1
To produce one ton of product of the present invention is example, and its batching is as follows:
Diabetic milk (or lactose-free milk; protein content 3%) 180kg; whey isolate protein (protein content 92%) 6.25kg; anhydrous butter oil 3.7kg; glucose 50kg; sucrose 40kg; maltodextrin 9.8kg; soybean oil 5kg; peanut oil 1kg; corn oil 3kg; phosphatidase 10 .2kg; guar gum 0.5kg; go alone ester 0.5kg; taurine 68g; nucleotides 29.7g; CPP 270g; DHA (DHA) 50g; arachidonic acid (ARA) 80g; lactoferrin 120g; galactooligosaccharide (GOS) 608g; FOS (FOS) 550g; choline 0.1063kg; inositol 0.0956kg; B B-complex accounts for 0.1453kg; complex mineral prime element 0.5944kg (in element), all the other are water.
Nucleotides comprises adenosine 5 '-phosphate 6.5g, guanosine 5 '-phosphate 2.2g, cytidine 5 '-phosphate 10g, uridine 5 '-phosphate 7g, inosine 5 '-phosphate 4g.
The weight portion that contains each nutrition composition in the B B-complex is as follows: vitamin A 82631, vitamin D
31327, vitamin E 1143807, vitamin C 12232261, vitamin K 4582, VB11 01375, vitamin B2 39329, vitamin B6 86608, nicotinic acid 506763, pantothenic acid 323816, folic acid 10289, biotin 1541.
Weight portion is meant the ratio umber of weight meter.
The weight portion of each component of complex mineral prime element is as follows: calcium 5904708, iron 77584, zinc 49921, iodine 1682, copper 5.106, manganese 414.
Embodiment 2
To produce one ton of product of the present invention is example, and its batching is as follows:
Diabetic milk (or lactose-free milk; protein content 3%) 250kg; whey isolate protein (protein content 92%) 8.5kg; anhydrous butter oil 7.4kg; glucose 50kg; sucrose 20kg; maltodextrin 9.1kg; soybean oil 5kg; peanut oil 1kg; corn oil 3kg; carragheen 0.1kg; guar gum 0.3kg; phosphatidase 10 .4kg; go alone ester 0.5kg; taurine 68g; nucleotides 40g; CPP 270g; DHA (DHA) 100g; arachidonic acid (ARA) 120g; lactoferrin 60g; galactooligosaccharide (GOS) 608g; FOS (FOS) 550g; choline 0.1163kg; inositol 0.1056kg; B B-complex accounts for 0.1439kg; complex mineral prime element 0.5090kg (in element), all the other are water.
The weight portion that contains each nutrition composition in the B B-complex is as follows: vitamin A 81510, vitamin D
31325, vitamin E 1138207, vitamin C 12147188, vitamin K 4273, vitamin B1 97282, vitamin B2 25784, vitamin B6 83128, nicotinic acid 500657, pantothenic acid 299609, folic acid 9864, biotin 1324.
Weight portion is meant the ratio umber of weight meter.
The weight portion of each component of complex mineral prime element is as follows: calcium 4963875, iron 77328, zinc 46499, iodine 1640, copper 4.874, manganese 387.
Nucleotides comprises adenosine 5 '-phosphate 8.5g, guanosine 5 '-phosphate 4.2g, cytidine 5 '-phosphate 12g, uridine 5 '-phosphate 9g, inosine 5 '-phosphate 6.3g.
Embodiment 3
To produce one ton of product of the present invention is example, and its batching is as follows:
Diabetic milk (or lactose-free milk; protein content 3%) 300kg; whey isolate protein (protein content 92%) 10.2kg; anhydrous butter oil 10.7kg; glucose 50kg; sucrose 12.4kg; soybean oil 5kg; peanut oil 1kg; corn oil 3kg; go alone ester 0.3kg; phosphatidase 11 kg; taurine 68g; nucleotides 29.7g; CPP 270g; DHA (DHA) 27g; arachidonic acid (ARA) 54g; lactoferrin 100g; galactooligosaccharide (GOS) 608g; FOS (FOS) 550g; choline 0.1363kg; inositol 0.1152kg; B B-complex accounts for 0.1427kg; complex mineral prime element 0.4381kg (in element), all the other are water.
The weight portion that contains each nutrition composition in the B B-complex is as follows: vitamin A 80669, vitamin D
31323, vitamin E 1134007, vitamin C 12061881, vitamin K 3962, vitamin B1 95180, vitamin B6 79598, nicotinic acid 494452, pantothenic acid 275335, folic acid 9511, biotin 1145.
Weight portion is meant the ratio umber of weight meter.
The weight portion of each component of complex mineral prime element is as follows: calcium 4258250, iron 77135, zinc 43934, iodine 1608, copper 4.681, manganese 365.
Nucleotides comprises adenosine 5 '-phosphate 6.5g, guanosine 5 '-phosphate 2.2g, cytidine 5 '-phosphate 10g, uridine 5 '-phosphate 7g, inosine 5 '-phosphate 4g.
Embodiment 4
To produce one ton of product of the present invention is example, and its batching is as follows:
Diabetic milk (or lactose-free milk; protein content 3%) 333kg; whey isolate protein (protein content 92%) 11.36kg; anhydrous butter oil 19.7kg; glucose 32kg; galactolipin 4.3kg; soybean oil 5kg; peanut oil 1kg; corn oil 3kg; go alone ester 0.3kg; phosphatidase 10 .8kg; taurine 68g; nucleotides 29.7g; CPP 270g; DHA (DHA) 15g; arachidonic acid (ARA) 20g; lactoferrin 100g; galactooligosaccharide (GOS) 608g; FOS (FOS) 550g; choline 0.1kg; inositol 0.09kg; B B-complex accounts for 0.1419kg; complex mineral prime element 0.3909kg (in element), all the other are water.
The weight portion that contains each nutrition composition in the B B-complex is as follows: vitamin A 80108, vitamin D
31322, vitamin E 1131207, vitamin C 12029583, vitamin K 3785, vitamin B1 94009, vitamin B6 78317, nicotinic acid 492104, pantothenic acid 261484, folic acid 9276, biotin 1025.
Weight portion is meant the ratio umber of weight meter.
The weight portion of each component of complex mineral prime element is as follows: calcium 3787833, iron 77007, zinc 42227, iodine 1586, copper 4.556, manganese 350.
Nucleotides comprises adenosine 5 '-phosphate 6.5g, guanosine 5 '-phosphate 2.2g, cytidine 5 '-phosphate 10g, uridine 5 '-phosphate 7g, inosine 5 '-phosphate 4g.
Embodiment 5
To produce one ton of product of the present invention is example, and its batching is as follows:
Diabetic milk (or lactose-free milk; protein content 3%) 500kg; whey isolate protein (protein content 92%) 13.64kg; sucrose 30kg; glucose 33kg; soybean oil 5kg; peanut oil 1kg; corn oil 3kg; phosphatidase 10 .5kg; go alone ester 0.4kg; anhydrous butter oil 2.18kg; taurine 68g; nucleotides 29.7g; CPP 270g; DHA (DHA) 27g; arachidonic acid (ARA) 54g; lactoferrin 100g; galactooligosaccharide (GOS) 608g; FOS (FOS) 550g; choline 0.1kg; inositol 0.09kg; B B-complex accounts for 0.1404kg; complex mineral prime element 0.2964kg (in element), all the other are water.
The weight portion that contains each nutrition composition in the B B-complex is as follows: vitamin A 78988, vitamin D
31319, vitamin E 1125607, vitamin C 11935500, vitamin K 3503, vitamin B1 90584, vitamin B6 74468, nicotinic acid 485261, pantothenic acid 239374, folic acid 8807, biotin 785.
Weight portion is meant the ratio umber of weight meter.
The weight portion of each component of complex mineral prime element is as follows: calcium 2847000, iron 76750, zinc 38802, iodine 1543, copper 4.296, manganese 320.
Nucleotides comprises adenosine 5 '-phosphate 6.5g, guanosine 5 '-phosphate 2.2g, cytidine 5 '-phosphate 10g, uridine 5 '-phosphate 7g, inosine 5 '-phosphate 4g.
Though below done to elaborate according to the design and the embodiment of the object of the invention; but those of ordinary skills can recognize; under the precondition that does not break away from the claim limited range; still can make various improvement and conversion to the present invention, and these improve and conversion still should belong to protection scope of the present invention.
The effect of product of the present invention is as follows:
Product of the present invention has carried out animal experiments such as acute toxicity test, genetic toxicity test, 30 days feeding trials, traditional teratogenicity test, proves that this product safety is nontoxic; Has the effect that promotes the mouse growth simultaneously.
Claims (5)
1. a low-lactose liquid breast that is applicable to 0-12 month baby is characterized in that: comprise diabetic milk or lactose-free milk, whey isolate protein, particular carbon hydrate, anhydrous butter oil, vegetable oil, emulsifying agent, taurine, nucleotides, CPP, DHA, arachidonic acid, lactoferrin, galactooligosaccharide, FOS, choline, inositol, B B-complex, complex mineral prime element, water; Wherein wt and ratio are:
Wherein diabetic milk or lactose-free milk account for 18%-50%, whey isolate protein accounts for 0.6%-1.72%, the particular carbon hydrate accounts for 3.1%-8.5%, anhydrous butter oil accounts for 0.37-1.97%, vegetable oil accounts for 0.35%-2.5%, emulsifying agent 0.01-0.6%, taurine accounts for 3-10mg/100g, nucleotides accounts for 1-7mg/100g, CPP accounts for 20-30mg/100g, DHA accounts for 1-21mg/100g, arachidonic acid accounts for 4-30mg/100g, lactoferrin accounts for 4-15mg/100g, galactooligosaccharide accounts for 50-70mg/100g, FOS accounts for 40-60mg/100g, choline accounts for 5-28mg/100g, inositol accounts for 5-28mg/100g, B B-complex accounts for 0.007%-0.03%, the complex mineral prime element is in element 0.00005%-0.08%, and all the other are water;
Wherein, described particular carbon hydrate is: one or more in glucose, starch, dextrin, sucrose, galactolipin, maltose, the corn syrup;
Wherein, described complex mineral prime element is one or more combinations in following, content in its every 100g liquid milk is: calcium 40-100mg, phosphorus 20-70mg, magnesium 4-10mg, potassium 50-140mg, iron 0.5-1.6mg, zinc 0.3-1mg, sodium 10-50mg, iodine 4-40 μ g, copper 30-100 μ g, manganese 3.4-75 μ g, wherein:
Iron is ferrous by grape acid, one or more iron preparations combinations of ferrous sulfate, ferrous lactate, ironic citrate, ferric pyrophosphate provide;
Zinc is provided by zinc sulfate, zinc gluconate, zinc lactate, one or more zinc preparation combinations of zinc chloride;
Calcium is provided by milk calcium, calcium citrate, calcium phosphate, calcium chloride, calcium carbonate, one or more calcium preparation combinations of calcium lactate;
Magnesium is provided by magnesium sulfate, magnesium chloride, one or more magnesium preparation combinations of magnesium citrate;
Iodine is provided by KI;
Manganese is provided by manganese sulfate;
Copper is provided by copper sulphate.
2. liquid breast as claimed in claim 1 is characterized in that: described whey isolate protein requires lactose content below 1%.
3. liquid breast as claimed in claim 1, it is characterized in that: described emulsifying agent is selected from: phosphatide, carragheen, guar gum, locust bean gum, monoglyceride, sucrose ester one or more combination; Its addition is the 0.01-0.6% weight ratio.
4. liquid breast as claimed in claim 1, it is characterized in that: described nucleotides is adenosine 5 '-phosphate, guanosine 5 '-phosphate, cytidine 5 '-phosphate, uridine 5 '-phosphate, inosine 5 '-phosphate, its ratio is conventional arbitrary proportion combination.
5. liquid breast as claimed in claim 1, it is characterized in that: described DHA derives from algae, DHA is used the stability material embedding before use, coating material is: converted starch, maltodextrin, when adding DHA, add the arachidonic acid of DHA weight more than 1.05 times.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100068259A CN101233876B (en) | 2008-02-02 | 2008-02-02 | Low lactose liquid state milk suitable for baby from 0 to 12 months old |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100068259A CN101233876B (en) | 2008-02-02 | 2008-02-02 | Low lactose liquid state milk suitable for baby from 0 to 12 months old |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101233876A CN101233876A (en) | 2008-08-06 |
CN101233876B true CN101233876B (en) | 2011-11-02 |
Family
ID=39917978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100068259A Active CN101233876B (en) | 2008-02-02 | 2008-02-02 | Low lactose liquid state milk suitable for baby from 0 to 12 months old |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101233876B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102613300A (en) * | 2012-04-24 | 2012-08-01 | 澳优乳业(中国)有限公司 | Infant formula milk powder for preventing diarrhea and preparation method thereof |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101904362B (en) * | 2010-08-10 | 2013-03-20 | 河北三元食品有限公司 | Soy-based infant powder and preparation method thereof |
US20120171231A1 (en) * | 2010-12-29 | 2012-07-05 | Anja Wittke | Use of nutritional compositions including lactoferrin in stimulating immune cells |
CN102511557B (en) * | 2011-12-29 | 2015-06-17 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
CN102550663A (en) * | 2011-12-31 | 2012-07-11 | 宁波市牛奶集团有限公司 | Milk for children |
CN103082000A (en) * | 2013-02-06 | 2013-05-08 | 内蒙古蒙牛乳业(集团)股份有限公司 | Low-lactose liquid milk product containing fish oil and production method thereof |
CN103211022A (en) * | 2013-04-24 | 2013-07-24 | 江西雄鹰乳业有限公司 | Intelligence reinforcing milk powder for children |
WO2015154260A1 (en) * | 2014-04-09 | 2015-10-15 | Nestle (China) Ltd. | Gender specific synthetic nutritional compositions and nutritional systems comprising them. |
CN106605709B (en) * | 2015-10-22 | 2020-11-13 | 内蒙古伊利实业集团股份有限公司 | Liquid milk suitable for children of 3-6 years old and preparation method thereof |
CN105660860A (en) * | 2016-01-13 | 2016-06-15 | 内蒙古蒙牛乳业(集团)股份有限公司 | Low-lactose dairy product for sports and preparation method thereof |
CN105831284A (en) * | 2016-03-31 | 2016-08-10 | 东北农业大学 | Lactose intolerance and protein allergy preventing formula milk powder for older infants of 6-12 months |
CN105638908A (en) * | 2016-03-31 | 2016-06-08 | 东北农业大学 | Formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy |
CN106689358A (en) * | 2016-11-15 | 2017-05-24 | 徐詹程 | Infant formula food for special medical purposes |
AU2018411731C1 (en) * | 2018-03-05 | 2022-06-16 | Agritechnology Pty Ltd | Lactose free milk products |
CN109548871A (en) * | 2018-10-30 | 2019-04-02 | 徐州汇尔康食品有限公司 | A kind of dairy products containing fish oil |
CN114190543B (en) * | 2021-12-20 | 2023-05-26 | 青岛圣桐营养食品有限公司 | Lactose-free formula food for infants with low osmotic pressure and special medical application |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107656A (en) * | 1994-04-05 | 1995-09-06 | 黑龙江省红光农场乳品厂 | Milk powder simulating breast milk for infants |
CN1439276A (en) * | 2003-04-03 | 2003-09-03 | 石家庄三鹿集团股份有限公司 | Baby milk powder |
CN1459234A (en) * | 2003-04-03 | 2003-12-03 | 石家庄三鹿集团股份有限公司 | Milk powder for bady and young children |
CN1459235A (en) * | 2003-04-03 | 2003-12-03 | 石家庄三鹿集团股份有限公司 | Milk powder for bady and its biological technical prodn. method |
CN1489914A (en) * | 2002-10-18 | 2004-04-21 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk for infants |
CN1672541A (en) * | 2005-04-21 | 2005-09-28 | 石家庄三鹿集团股份有限公司 | Pregnant woman benefiting milk powder |
CN1792194A (en) * | 2006-01-06 | 2006-06-28 | 石家庄三鹿集团股份有限公司 | Formula milk powder for babies |
CN101095433A (en) * | 2007-08-03 | 2008-01-02 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk suitable for 1 to 3 years old children and the method for producing the same |
-
2008
- 2008-02-02 CN CN2008100068259A patent/CN101233876B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107656A (en) * | 1994-04-05 | 1995-09-06 | 黑龙江省红光农场乳品厂 | Milk powder simulating breast milk for infants |
CN1489914A (en) * | 2002-10-18 | 2004-04-21 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk for infants |
CN1439276A (en) * | 2003-04-03 | 2003-09-03 | 石家庄三鹿集团股份有限公司 | Baby milk powder |
CN1459234A (en) * | 2003-04-03 | 2003-12-03 | 石家庄三鹿集团股份有限公司 | Milk powder for bady and young children |
CN1459235A (en) * | 2003-04-03 | 2003-12-03 | 石家庄三鹿集团股份有限公司 | Milk powder for bady and its biological technical prodn. method |
CN1672541A (en) * | 2005-04-21 | 2005-09-28 | 石家庄三鹿集团股份有限公司 | Pregnant woman benefiting milk powder |
CN1792194A (en) * | 2006-01-06 | 2006-06-28 | 石家庄三鹿集团股份有限公司 | Formula milk powder for babies |
CN101095433A (en) * | 2007-08-03 | 2008-01-02 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk suitable for 1 to 3 years old children and the method for producing the same |
Non-Patent Citations (4)
Title |
---|
刘金杰等.液态婴儿奶.中国乳品工业30 5.2002,30(5),83-84. |
刘金杰等.液态婴儿奶.中国乳品工业30 5.2002,30(5),83-84. * |
赵显峰等.乳糖不耐受以及解决方法的研究动态.中国学校卫生28 12.2007,28(12),1151-1153. |
赵显峰等.乳糖不耐受以及解决方法的研究动态.中国学校卫生28 12.2007,28(12),1151-1153. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102613300A (en) * | 2012-04-24 | 2012-08-01 | 澳优乳业(中国)有限公司 | Infant formula milk powder for preventing diarrhea and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101233876A (en) | 2008-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101233876B (en) | Low lactose liquid state milk suitable for baby from 0 to 12 months old | |
CN101233873B (en) | Liquid state milk suitable for baby from newborn to six months old | |
CN101233874B (en) | Liquid state milk suitable for baby from 12 to 36 months old | |
CN101218940B (en) | DHA added liquid condition milk for baby | |
CN101427786A (en) | Liquid state milk with additive algae DHA suitable for baby from 12 to 36 months old | |
CN101427797A (en) | Liquid milk with additive arachidonic acid suitable for baby of 0 to 6 months old | |
CN101313714A (en) | Liquid milk with additive vitamin suitable for baby of 12 to 36 months ages | |
CN101313704A (en) | Liquid milk for baby of birth time to 12 months ages and method using online addition technique | |
CN101218941B (en) | Mineral matter element added liquid condition milk for baby | |
CN101313721A (en) | Liquid milk with additive serum albumin suitable for baby of birth time to 6 months ages | |
CN101218942B (en) | Serum albumin added liquid condition milk for baby | |
CN101313700B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method of injection type direct disinfection | |
CN101233875B (en) | Liquid state milk suitable for baby from 6 to 12 months old | |
CN101317609B (en) | Liquid milk with additive serum albumin for baby of 6 to 12 months age | |
CN101313699B (en) | Liquid milk for baby of 12 to 36 months ages and preparation method for injection type direct disinfection | |
CN101317598B (en) | Liquid milk for baby of zero to 6 months age and preparation using injection type direct disinfection | |
CN101317596B (en) | Liquid milk for baby of 12 to 36 months age and method for using on-line addition technique thereof | |
CN101361509B (en) | Liquid mild added with lactose suitable for 0-6 month baby | |
CN101317602B (en) | Liquid milk with additive plant fat for baby of birth to 6 months age | |
CN101317608B (en) | Liquid milk with additive serum albumin for baby of 12 to 36 months age | |
CN101313712B (en) | Liquid milk with additive lactose suitable for baby of 12 to 36 months ages | |
CN101313708B (en) | Liquid milk with additive carbohydrate suitable for baby of 6 to 12 months ages | |
CN101361508B (en) | Liquid milk added with mineral matter suitable for 12-36 month baby | |
CN101313709B (en) | Liquid milk with additive mineral matter suitable for baby of 6 to 12 months ages | |
CN101317603B (en) | Liquid milk with additive mineral matter for baby of birth to 6 months age |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |